Authors:
Doyle, IS
Hollmann, CA
Crispe, IN
Owens, T
Citation: Is. Doyle et al., Specific blockade by CD54 and MHC II of CD40-mediated signaling for B cellproliferation and survival, EXP CELL RE, 265(2), 2001, pp. 312-318
Authors:
Hassan-Zahraee, M
Tran, EH
Bourbonniere, L
Owens, T
Citation: M. Hassan-zahraee et al., Elevated interferon-gamma in CNS inflammatory disease: a potential complication for bone marrow reconstitution in MS, J NEUROIMM, 108(1-2), 2000, pp. 40-44
Citation: Eh. Tran et al., IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines, J IMMUNOL, 164(5), 2000, pp. 2759-2768
Authors:
Gunning, JW
Hoddinott, J
Kinsey, B
Owens, T
Citation: Jw. Gunning et al., Revisiting forever gained: Income dynamics in the resettlement areas of Zimbabwe, 1983-96, J DEV STUD, 36(6), 2000, pp. 131-154
Citation: Eh. Tran et al., Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1 alpha or its CCR5 receptor, EUR J IMMUN, 30(5), 2000, pp. 1410-1415
Citation: Ml. Krakowski et T. Owens, Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation, EUR J IMMUN, 30(4), 2000, pp. 1002-1009
Authors:
Jensen, MB
Hegelund, IV
Poulsen, FR
Owens, T
Zimmer, J
Finsen, B
Citation: Mb. Jensen et al., Microglial reactivity correlates to the density and the myelination of theanterogradely degenerating axons and terminals following perforant path denervation of the mouse fascia dentata, NEUROSCIENC, 93(2), 1999, pp. 507-518
Authors:
Leibson, C
Owens, T
O'Brien, P
Waring, S
Tangalos, E
Hanson, V
Plevak, M
Kokmen, E
Citation: C. Leibson et al., Use of physician and acute care services by persons with and without Alzheimer's disease: A population-based comparison, J AM GER SO, 47(7), 1999, pp. 864-869
Authors:
Renno, T
Taupin, V
Bourbonniere, L
Verge, G
Tran, E
De Simone, R
Krakowski, M
Rodriguez, M
Peterson, A
Owens, T
Citation: T. Renno et al., Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE, MOL CELL NE, 12(6), 1998, pp. 376-389
Authors:
Willenborg, DO
Racke, MK
Lovett-Racke, AE
Hoffman, LM
Karpus, WJ
Owens, T
Citation: Do. Willenborg et al., Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 843-844
Citation: T. Owens et al., Chemokine regulation of CNS T-cell infiltration in experimental autoimmuneencephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 846-847
Authors:
Willenborg, DO
Owens, T
Begolka, WS
Miller, SD
Citation: Do. Willenborg et al., Cytokines and antibodies in myelin oligodendrocyte glycoptotein-induced experimental allergic encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 847-848
Citation: T. Owens et al., Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Discussion, RES IMMUNOL, 149(9), 1998, pp. 849-850
Citation: Ws. Begolka et al., The comeback of the elusive "suppressor" cell: an update on the regulatorynetwork in EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 850-851
Authors:
Hoffman, LM
Karpus, WJ
Owens, T
Begolka, WS
Miller, D
Citation: Lm. Hoffman et al., Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur? Discussion, RES IMMUNOL, 149(9), 1998, pp. 851-852
Citation: Bm. Segal et al., TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein - Discussion, RES IMMUNOL, 149(9), 1998, pp. 852-854
Authors:
Willenborg, DO
Owens, T
Segal, BM
Begolka, WS
Miller, SD
Citation: Do. Willenborg et al., T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification - Discussion, RES IMMUNOL, 149(9), 1998, pp. 854-855
Authors:
Chagnon, F
Lamarre, A
Lachance, C
Krakowski, M
Owens, T
Laliberte, JF
Talbot, PJ
Citation: F. Chagnon et al., Characterization of the expression and immunogenicity of the ns4b protein of human coronavirus 229E, CAN J MICRO, 44(10), 1998, pp. 1012-1017